USPTO serial 79439888
EPISIL
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- MANCA, ALBERTO I
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EPISIL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lauren Beth Emerson
One North Lexington Avenue, Suite 1200White Plains, NY 10601United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for local treatment of pain associated with oral mucositis and stomatitis, administered via a medical device; veterinary preparations for local treatment of pain associated with oral mucositis and stomatitis, administered via a medical device, none of the aforementioned goods for gynecological pharmaceutical preparations and hygienic products related thereto; analgesics. | ACTIVE | — |
| 010 | Inhalers for medical purposes, sold empty; nebulizers for medical purposes; pumps for medical purposes, namely, pumps for administering pharmaceutical preparations for the local treatment of pain associated with oral mucositis and stomatitis administered via a medical device; dosage dispensers for medical use for administering medicine to patients; injectors for medical purposes, namely, medical injectors for administering pharmaceutical preparations for the local treatment of pain associated with oral mucositis and stomatitis administered via a medical device, sold empty; syringes for injections; medical apparatus and instruments, namely, medical apparatus and instruments for administering pharmaceutical preparations for the local treatment of pain associated with oral mucositis and stomatitis administered via a medical device. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 3, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 23, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 23, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 13, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 11, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 30, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 25, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |